Community Health Worker Support for Preeclampsia
(AW2H Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a support program for Black postpartum patients who have experienced preeclampsia (a pregnancy complication with high blood pressure) or other pregnancy issues. The goal is to determine if community health workers can help control blood pressure after childbirth and reduce long-term heart disease risks. Participants will receive either usual postpartum care or additional visits and support from community health workers (Community Health Worker Intervention). This trial suits Black individuals who had complications like high blood pressure during pregnancy and plan to deliver at UAB Hospital. As an unphased trial, this study offers a unique opportunity to contribute to research that could improve postpartum care and long-term health outcomes for Black patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this community health worker intervention is safe for postpartum patients with preeclampsia?
Research shows that community health worker programs are generally safe for participants. These programs involve trained community members who provide support and education to help patients manage their health. Although specific data on the safety of these programs for new mothers with preeclampsia is limited, they have been used in other health areas without major safety issues.
This trial examines whether community health workers can help control blood pressure and prevent long-term heart problems. The trial is in the "Not Applicable" phase, focusing on the program's practicality and acceptability rather than safety. However, since community health worker programs are widely used in healthcare, they are expected to be safe.
Overall, there is no direct evidence of harm from these programs, making them a potentially safe option for supporting new mothers with preeclampsia.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential of community health workers to provide vital support in managing preeclampsia, a condition that currently relies on standard postpartum care like regular monitoring and medication. Unlike typical treatments, this approach involves community health workers who offer personalized visits and support, potentially improving patient outcomes by addressing social and emotional needs alongside medical ones. This could lead to a more holistic and accessible way to manage preeclampsia, offering benefits beyond what conventional care can provide.
What evidence suggests that the Community Health Worker Intervention is effective for preeclampsia?
Research has shown that community health workers can effectively assist people with preeclampsia by improving their health. In this trial, participants will receive either usual postpartum care or usual care combined with community health worker intervention. One study involved individuals who experienced preeclampsia and found that personalized support from these workers helped manage blood pressure and prevent future heart issues. Another study discovered that including community health workers in care plans addressed the specific needs of new mothers, leading to better health management. These workers provide personalized advice, education, and support during the crucial postpartum period. Overall, this approach has shown promise in enhancing care for new mothers with preeclampsia.56789
Who Is on the Research Team?
Jesse E Rattan
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for Black individuals between the ages of 16-56 who are experiencing adverse pregnancy outcomes like preeclampsia, preterm birth, and others. Participants must be planning to deliver at UAB Hospital, speak and write English, and not be due for delivery at enrollment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive cardiovascular disease prevention education and community health worker support
Follow-up
Participants are monitored for satisfaction and health outcomes, including blood pressure and primary care visit scheduling
What Are the Treatments Tested in This Trial?
Interventions
- Community Health Worker Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator
American Heart Association
Collaborator
National Institutes of Health (NIH)
Collaborator